Reported Earnings • May 27
Full year 2026 earnings released: EPS: ₹8.66 (vs ₹2.08 in FY 2025) Full year 2026 results: EPS: ₹8.66 (up from ₹2.08 in FY 2025). Revenue: ₹217.6m (up 30% from FY 2025). Net income: ₹31.4m (up 319% from FY 2025). Profit margin: 14% (up from 4.5% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Announcement • May 16
Shree Pacetronix Limited to Report Q4, 2026 Results on May 25, 2026 Shree Pacetronix Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 25, 2026 Valuation Update With 7 Day Price Move • Mar 27
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹98.30, the stock trades at a trailing P/E ratio of 14.8x. Average trailing P/E is 18x in the Medical Equipment industry in India. Negligible returns to shareholders over past three years. Valuation Update With 7 Day Price Move • Mar 11
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹123, the stock trades at a trailing P/E ratio of 18.2x. Average trailing P/E is 21x in the Medical Equipment industry in India. Total returns to shareholders of 30% over the past three years. Reported Earnings • Feb 15
Third quarter 2026 earnings released: EPS: ₹0.16 (vs ₹0.31 loss in 3Q 2025) Third quarter 2026 results: EPS: ₹0.16 (up from ₹0.31 loss in 3Q 2025). Revenue: ₹43.6m (up 20% from 3Q 2025). Net income: ₹575.0k (up ₹1.69m from 3Q 2025). Profit margin: 1.3% (up from net loss in 3Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Feb 13
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₹165, the stock trades at a trailing P/E ratio of 26.1x. Average trailing P/E is 26x in the Medical Equipment industry in India. Total returns to shareholders of 53% over the past three years. Announcement • Feb 04
Shree Pacetronix Limited to Report Q3, 2026 Results on Feb 13, 2026 Shree Pacetronix Limited announced that they will report Q3, 2026 results on Feb 13, 2026 Valuation Update With 7 Day Price Move • Jan 05
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₹156, the stock trades at a trailing P/E ratio of 24.7x. Average trailing P/E is 28x in the Medical Equipment industry in India. Total returns to shareholders of 69% over the past three years. New Risk • Jan 02
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹633.9m market cap, or US$7.03m). Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Revenue is less than US$5m (₹198m revenue, or US$2.2m). Valuation Update With 7 Day Price Move • Dec 18
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹226, the stock trades at a trailing P/E ratio of 35.7x. Average trailing P/E is 34x in the Medical Equipment industry in India. Total returns to shareholders of 88% over the past three years. New Risk • Nov 26
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹888.5m (US$9.96m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹888.5m market cap, or US$9.96m). Minor Risk Revenue is less than US$5m (₹198m revenue, or US$2.2m). Reported Earnings • Nov 04
Second quarter 2026 earnings released: EPS: ₹3.64 (vs ₹0.09 in 2Q 2025) Second quarter 2026 results: EPS: ₹3.64 (up from ₹0.09 in 2Q 2025). Revenue: ₹66.2m (up 64% from 2Q 2025). Net income: ₹13.1m (up ₹12.8m from 2Q 2025). Profit margin: 20% (up from 0.8% in 2Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings. Announcement • Oct 24
Shree Pacetronix Limited to Report Q2, 2026 Results on Nov 01, 2025 Shree Pacetronix Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 01, 2025 Announcement • Aug 08
Shree Pacetronix Limited announced that it expects to receive INR 10.652513 million in funding Shree Pacetronix Limited announced a private placement and entered into a subscription agreement to issue up to 75,150 Equity shares of face value INR 10 at an issue price of INR 81 for aggregate proceeds of INR 6,087,150, up to 75,150 fully convertible Equity Warrants (Series A Warrants) at an issue price of INR 20.25 for aggregate proceeds of INR 1,521,787.5 and 150,300 fully Convertible Equity Warrants (Series B Warrants) at a price of INR 20.25 for aggregate proceeds of INR 3,043,575 and total gross proceeds amounting to INR 10,652,512.5 on August 7, 2025. Each warrant will carry a right exercisable by the warrant holder to subscribe to one eqyuty share of face value of INR 10.The transaction has been approved by the board of Directors of the company and is subject to the approval of shareholders. The transaction will include participation from Akash Sethi. Reported Earnings • Aug 08
First quarter 2026 earnings released: EPS: ₹1.85 (vs ₹1.03 in 1Q 2025) First quarter 2026 results: EPS: ₹1.85 (up from ₹1.03 in 1Q 2025). Revenue: ₹53.7m (up 11% from 1Q 2025). Net income: ₹6.65m (up 78% from 1Q 2025). Profit margin: 12% (up from 7.7% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 63% per year, which means it is well ahead of earnings. Announcement • Aug 07
Shree Pacetronix Limited, Annual General Meeting, Sep 03, 2025 Shree Pacetronix Limited, Annual General Meeting, Sep 03, 2025, at 13:00 Indian Standard Time. Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment improves as stock rises 36% After last week's 36% share price gain to ₹107, the stock trades at a trailing P/E ratio of 51.1x. Average trailing P/E is 27x in the Medical Equipment industry in India. Total returns to shareholders of 271% over the past three years. Announcement • Aug 04
Shree Pacetronix Limited to Report Q1, 2026 Results on Aug 07, 2025 Shree Pacetronix Limited announced that they will report Q1, 2026 results on Aug 07, 2025 New Risk • Jul 04
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹305.0m market cap, or US$3.57m). Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Profit margins are more than 30% lower than last year (4.5% net profit margin). Revenue is less than US$5m (₹168m revenue, or US$2.0m). Valuation Update With 7 Day Price Move • Jul 02
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to ₹92.20, the stock trades at a trailing P/E ratio of 44.3x. Average trailing P/E is 31x in the Medical Equipment industry in India. Total returns to shareholders of 384% over the past three years. Reported Earnings • Jun 02
Full year 2025 earnings released: EPS: ₹2.08 (vs ₹9.33 in FY 2024) Full year 2025 results: EPS: ₹2.08 (down from ₹9.33 in FY 2024). Revenue: ₹169.2m (down 23% from FY 2024). Net income: ₹7.50m (down 78% from FY 2024). Profit margin: 4.4% (down from 15% in FY 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 58% per year, which means it is tracking significantly ahead of earnings growth. Announcement • May 21
Shree Pacetronix Limited to Report Q4, 2025 Results on May 30, 2025 Shree Pacetronix Limited announced that they will report Q4, 2025 results on May 30, 2025 Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹71.91, the stock trades at a trailing P/E ratio of 15x. Average trailing P/E is 23x in the Medical Equipment industry in India. Total returns to shareholders of 255% over the past three years. Valuation Update With 7 Day Price Move • Feb 04
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₹84.75, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 23x in the Medical Equipment industry in India. Total returns to shareholders of 253% over the past three years. Reported Earnings • Jan 29
Third quarter 2025 earnings released: ₹0.31 loss per share (vs ₹1.10 profit in 3Q 2024) Third quarter 2025 results: ₹0.31 loss per share (down from ₹1.10 profit in 3Q 2024). Revenue: ₹36.5m (down 15% from 3Q 2024). Net loss: ₹1.11m (down 128% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Jan 22
Shree Pacetronix Limited to Report Q3, 2025 Results on Jan 28, 2025 Shree Pacetronix Limited announced that they will report Q3, 2025 results on Jan 28, 2025 New Risk • Oct 22
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 11% Last year net profit margin: 17% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). High level of non-cash earnings (25% accrual ratio). Market cap is less than US$10m (₹455.7m market cap, or US$5.42m). Minor Risks Profit margins are more than 30% lower than last year (11% net profit margin). Revenue is less than US$5m (₹198m revenue, or US$2.4m). Reported Earnings • Oct 22
Second quarter 2025 earnings released: EPS: ₹0.09 (vs ₹1.85 in 2Q 2024) Second quarter 2025 results: EPS: ₹0.09 (down from ₹1.85 in 2Q 2024). Revenue: ₹40.4m (down 23% from 2Q 2024). Net income: ₹337.0k (down 95% from 2Q 2024). Profit margin: 0.8% (down from 13% in 2Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has increased by 108% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Oct 21
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₹127, the stock trades at a trailing P/E ratio of 15.9x. Average trailing P/E is 34x in the Medical Equipment industry in India. Total returns to shareholders of 802% over the past three years. Announcement • Oct 11
Shree Pacetronix Limited to Report First Half, 2025 Results on Oct 19, 2024 Shree Pacetronix Limited announced that they will report first half, 2025 results on Oct 19, 2024 Valuation Update With 7 Day Price Move • Aug 21
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₹181, the stock trades at a trailing P/E ratio of 22.7x. Average trailing P/E is 31x in the Medical Equipment industry in India. Total returns to shareholders of 894% over the past three years. Announcement • Aug 12
Shree Pacetronix Limited, Annual General Meeting, Sep 20, 2024 Shree Pacetronix Limited, Annual General Meeting, Sep 20, 2024, at 11:30 Indian Standard Time. Reported Earnings • Aug 11
First quarter 2025 earnings released: EPS: ₹1.03 (vs ₹2.40 in 1Q 2024) First quarter 2025 results: EPS: ₹1.03 (down from ₹2.40 in 1Q 2024). Revenue: ₹49.1m (down 16% from 1Q 2024). Net income: ₹3.73m (down 57% from 1Q 2024). Profit margin: 7.6% (down from 15% in 1Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has increased by 92% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 09
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹180, the stock trades at a trailing P/E ratio of 19.3x. Average trailing P/E is 29x in the Medical Equipment industry in India. Total returns to shareholders of 1,300% over the past three years. Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹234, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 26x in the Medical Equipment industry in India. Total returns to shareholders of 2,578% over the past three years. New Risk • Jun 02
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.5% average weekly change). Market cap is less than US$10m (₹778.4m market cap, or US$9.33m). Minor Risk Revenue is less than US$5m (₹229m revenue, or US$2.7m). Announcement • May 23
Shree Pacetronix Limited to Report Q4, 2024 Results on May 30, 2024 Shree Pacetronix Limited announced that they will report Q4, 2024 results on May 30, 2024 Valuation Update With 7 Day Price Move • Apr 25
Investor sentiment improves as stock rises 30% After last week's 30% share price gain to ₹232, the stock trades at a trailing P/E ratio of 21.5x. Average trailing P/E is 32x in the Medical Equipment industry in India. Total returns to shareholders of 1,909% over the past three years. New Risk • Apr 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹690.4m market cap, or US$8.28m). Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Revenue is less than US$5m (₹229m revenue, or US$2.7m). Valuation Update With 7 Day Price Move • Apr 05
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹177, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 25x in the Medical Equipment industry in India. Total returns to shareholders of 1,432% over the past three years. Valuation Update With 7 Day Price Move • Feb 06
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to ₹148, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 36x in the Medical Equipment industry in India. Total returns to shareholders of 1,496% over the past three years. Reported Earnings • Jan 31
Third quarter 2024 earnings released: EPS: ₹1.10 (vs ₹1.71 in 3Q 2023) Third quarter 2024 results: EPS: ₹1.10 (down from ₹1.71 in 3Q 2023). Revenue: ₹43.3m (down 17% from 3Q 2023). Net income: ₹3.97m (down 36% from 3Q 2023). Profit margin: 9.2% (down from 12% in 3Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has increased by 164% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Jan 24
Shree Pacetronix Limited to Report Q3, 2023 Results on Jan 30, 2024 Shree Pacetronix Limited announced that they will report Q3, 2023 results on Jan 30, 2024 Valuation Update With 7 Day Price Move • Dec 08
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₹222, the stock trades at a trailing P/E ratio of 19.4x. Average trailing P/E is 38x in the Medical Equipment industry in India. Total returns to shareholders of 1,732% over the past three years. New Risk • Dec 07
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹827.3m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (40% accrual ratio). Market cap is less than US$10m (₹827.3m market cap, or US$9.92m). Minor Risk Revenue is less than US$5m (₹238m revenue, or US$2.9m). Reported Earnings • Nov 11
Second quarter 2024 earnings released: EPS: ₹1.85 (vs ₹0.79 in 2Q 2023) Second quarter 2024 results: EPS: ₹1.85 (up from ₹0.79 in 2Q 2023). Revenue: ₹52.5m (up 26% from 2Q 2023). Net income: ₹6.65m (up 135% from 2Q 2023). Profit margin: 13% (up from 6.8% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has increased by 213% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Sep 21
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹341, the stock trades at a trailing P/E ratio of 33x. Average trailing P/E is 31x in the Medical Equipment industry in India. Total returns to shareholders of 2,745% over the past three years. Reported Earnings • Aug 18
First quarter 2024 earnings released: EPS: ₹2.40 (vs ₹1.12 in 1Q 2023) First quarter 2024 results: EPS: ₹2.40 (up from ₹1.12 in 1Q 2023). Revenue: ₹59.1m (up 76% from 1Q 2023). Net income: ₹8.65m (up 114% from 1Q 2023). Profit margin: 15% (up from 12% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 100% per year but the company’s share price has increased by 176% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Aug 15
Shree Pacetronix Limited, Annual General Meeting, Sep 15, 2023 Shree Pacetronix Limited, Annual General Meeting, Sep 15, 2023, at 11:30 Indian Standard Time. Announcement • Aug 04
Shree Pacetronix Limited to Report Q1, 2024 Results on Aug 14, 2023 Shree Pacetronix Limited announced that they will report Q1, 2024 results on Aug 14, 2023 Valuation Update With 7 Day Price Move • Jul 26
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹231, the stock trades at a trailing P/E ratio of 25.5x. Average trailing P/E is 30x in the Medical Equipment industry in India. Total returns to shareholders of 1,813% over the past three years. Valuation Update With 7 Day Price Move • Jun 06
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to ₹164, the stock trades at a trailing P/E ratio of 18.2x. Average trailing P/E is 25x in the Medical Equipment industry in India. Total returns to shareholders of 678% over the past year. Reported Earnings • Jun 01
Full year 2023 earnings released: EPS: ₹9.06 (vs ₹2.17 in FY 2022) Full year 2023 results: EPS: ₹9.06 (up from ₹2.17 in FY 2022). Revenue: ₹203.5m (up 120% from FY 2022). Net income: ₹32.6m (up 318% from FY 2022). Profit margin: 16% (up from 8.5% in FY 2022). The increase in margin was driven by higher revenue. Announcement • May 25
Shree Pacetronix Limited to Report Q4, 2023 Results on May 30, 2023 Shree Pacetronix Limited announced that they will report Q4, 2023 results on May 30, 2023 Valuation Update With 7 Day Price Move • May 02
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹119, the stock trades at a trailing P/E ratio of 26.8x. Average trailing P/E is 27x in the Medical Equipment industry in India. Total returns to shareholders of 967% over the past three years. Valuation Update With 7 Day Price Move • Apr 11
Investor sentiment improves as stock rises 25% After last week's 25% share price gain to ₹125, the stock trades at a trailing P/E ratio of 28x. Average trailing P/E is 25x in the Medical Equipment industry in India. Total returns to shareholders of 1,015% over the past three years. Reported Earnings • Feb 19
Third quarter 2023 earnings released: EPS: ₹1.71 (vs ₹0.20 in 3Q 2022) Third quarter 2023 results: EPS: ₹1.71 (up from ₹0.20 in 3Q 2022). Revenue: ₹52.1m (up 135% from 3Q 2022). Net income: ₹6.16m (up ₹5.43m from 3Q 2022). Profit margin: 12% (up from 3.3% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has increased by 108% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Feb 17
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹107, the stock trades at a trailing P/E ratio of 36.3x. Average trailing P/E is 32x in the Medical Equipment industry in India. Total returns to shareholders of 795% over the past three years. Announcement • Feb 05
Shree Pacetronix Limited to Report Q3, 2023 Results on Feb 13, 2023 Shree Pacetronix Limited announced that they will report Q3, 2023 results on Feb 13, 2023 Valuation Update With 7 Day Price Move • Jan 12
Investor sentiment improved over the past week After last week's 15% share price gain to ₹107, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 33x in the Medical Equipment industry in India. Total returns to shareholders of 788% over the past three years. Valuation Update With 7 Day Price Move • Dec 14
Investor sentiment improved over the past week After last week's 21% share price gain to ₹132, the stock trades at a trailing P/E ratio of 44.7x. Average trailing P/E is 39x in the Medical Equipment industry in India. Total returns to shareholders of 1,000% over the past three years. Valuation Update With 7 Day Price Move • Nov 21
Investor sentiment deteriorated over the past week After last week's 23% share price decline to ₹146, the stock trades at a trailing P/E ratio of 49.4x. Average trailing P/E is 40x in the Medical Equipment industry in India. Total returns to shareholders of 1,076% over the past three years. Reported Earnings • Nov 20
Second quarter 2023 earnings released: EPS: ₹0.79 (vs ₹1.07 in 2Q 2022) Second quarter 2023 results: EPS: ₹0.79 (down from ₹1.07 in 2Q 2022). Revenue: ₹42.0m (up 46% from 2Q 2022). Net income: ₹2.83m (down 27% from 2Q 2022). Profit margin: 6.7% (down from 13% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has increased by 131% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Nov 06
Shree Pacetronix Limited to Report Q2, 2023 Results on Nov 14, 2022 Shree Pacetronix Limited announced that they will report Q2, 2023 results on Nov 14, 2022 Valuation Update With 7 Day Price Move • Oct 12
Investor sentiment improved over the past week After last week's 18% share price gain to ₹68.35, the stock trades at a trailing P/E ratio of 21.1x. Average trailing P/E is 30x in the Medical Equipment industry in India. Total returns to shareholders of 431% over the past three years. Valuation Update With 7 Day Price Move • Sep 23
Investor sentiment improved over the past week After last week's 18% share price gain to ₹59.00, the stock trades at a trailing P/E ratio of 18.2x. Average trailing P/E is 32x in the Medical Equipment industry in India. Total returns to shareholders of 346% over the past year. Valuation Update With 7 Day Price Move • Aug 18
Investor sentiment improved over the past week After last week's 16% share price gain to ₹32.55, the stock trades at a trailing P/E ratio of 15x. Average trailing P/E is 35x in the Medical Equipment industry in India. Total returns to shareholders of 54% over the past year. Announcement • Aug 07
Shree Pacetronix Limited to Report Q1, 2023 Results on Aug 13, 2022 Shree Pacetronix Limited announced that they will report Q1, 2023 results on Aug 13, 2022 Reported Earnings • Jul 31
Full year 2022 earnings released: EPS: ₹2.17 (vs ₹0.15 in FY 2021) Full year 2022 results: EPS: ₹2.17 (up from ₹0.15 in FY 2021). Revenue: ₹92.3m (up 22% from FY 2021). Net income: ₹7.81m (up ₹7.28m from FY 2021). Profit margin: 8.5% (up from 0.7% in FY 2021). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Jul 20
Investor sentiment improved over the past week After last week's 15% share price gain to ₹21.00, the stock trades at a trailing P/E ratio of 9.7x. Average trailing P/E is 31x in the Medical Equipment industry in India. Total returns to shareholders of 28% over the past year. Valuation Update With 7 Day Price Move • Jun 03
Investor sentiment improved over the past week After last week's 16% share price gain to ₹21.15, the stock trades at a trailing P/E ratio of 17.4x. Average trailing P/E is 24x in the Medical Equipment industry in India. Total returns to shareholders of 119% over the past year. Announcement • May 31
Shree Pacetronix Limited to Report Q4, 2022 Results on May 30, 2022 Shree Pacetronix Limited announced that they will report Q4, 2022 results on May 30, 2022 Valuation Update With 7 Day Price Move • May 11
Investor sentiment deteriorated over the past week After last week's 18% share price decline to ₹17.40, the stock trades at a trailing P/E ratio of 14.3x. Average trailing P/E is 24x in the Medical Equipment industry in India. Total returns to shareholders of 44% over the past year. Buying Opportunity • May 11
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 34%. The fair value is estimated to be ₹21.88, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.0% over the last 3 years. Earnings per share has grown by 33%. Announcement • May 08
Shree Pacetronix Limited Announces Management Changes Shree Pacetronix Limited announced at the board meeting held on May 5, 2022 that the company approved Mahesh Purohit, Rajesh Kumar Bhale and Varun Rawat has resigned from the position of Independent Director of the company with effect from close of working hours of 05th May, 2022. The Board of Directors have approved the reconstitution of certain committees of the Board of Directors with effect from 06th May, 2022 as Ms. Manali Tongia as member of Audit Committee, Nomination and Remuneration Committee and Stakeholders' Relationship Committee, Sushil Kumar Patni as Chairman of Stakeholders' Relationship Committee and Atul Kumar Sethi as member of Stakeholders' Relationship Committee. Board Change • Apr 27
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. Additional Non-Executive Independent Woman Director Manali Tongia was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Mar 29
Shree Pacetronix Limited Announces Board Resignations Shree Pacetronix Limited announced resignation of Mrs. Amita Sethi and Mr. Vikas Gokhale has resigned from the position of Whole time Director of the company with effect from March 28, 2022. Valuation Update With 7 Day Price Move • Mar 28
Investor sentiment deteriorated over the past week After last week's 18% share price decline to ₹21.50, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 27x in the Medical Equipment industry in India. Total returns to shareholders of 67% over the past three years. Valuation Update With 7 Day Price Move • Mar 08
Investor sentiment improved over the past week After last week's 15% share price gain to ₹26.30, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 25x in the Medical Equipment industry in India. Total returns to shareholders of 139% over the past year. Announcement • Feb 26
Shree Pacetronix Limited Announces Resignation of Harshita Jindal as Company Secretary and Compliance Officer Shree Pacetronix Limited announced resignation of Harshita Jindal, Company Secretary and Compliance officer (Key Managerial Personnel) of the Company has tendered her resignation due to personal reasons and she shall cease to be Company Secretary and Compliance officer w.e.f. close of working hours of February 25, 2022. Reported Earnings • Feb 17
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹0.20 (up from ₹0.07 in 3Q 2021). Revenue: ₹22.2m (up 16% from 3Q 2021). Net income: ₹728.0k (up 205% from 3Q 2021). Profit margin: 3.3% (up from 1.2% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Valuation Update With 7 Day Price Move • Dec 20
Investor sentiment improved over the past week After last week's 19% share price gain to ₹30.50, the stock trades at a trailing P/E ratio of 28.3x. Average trailing P/E is 28x in the Medical Equipment industry in India. Total returns to shareholders of 142% over the past year. Valuation Update With 7 Day Price Move • Nov 24
Investor sentiment improved over the past week After last week's 21% share price gain to ₹20.37, the stock trades at a trailing P/E ratio of 18.9x. Average trailing P/E is 30x in the Medical Equipment industry in India. Total returns to shareholders of 88% over the past year. Board Change • Sep 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 3 highly experienced directors. Non-Executive Independent Director Mahesh Purohit was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Valuation Update With 7 Day Price Move • Jul 07
Investor sentiment improved over the past week After last week's 21% share price gain to ₹11.68, the stock trades at a trailing P/E ratio of 77.9x. Average trailing P/E is 22x in the Medical Equipment industry in India. Total returns to shareholders of 6.2% over the past year. Reported Earnings • Jul 04
Full year 2021 earnings released: EPS ₹0.15 (vs ₹0.66 in FY 2020) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹76.1m (down 13% from FY 2020). Net income: ₹530.0k (down 78% from FY 2020). Profit margin: 0.7% (down from 2.7% in FY 2020). The decrease in margin was driven by lower revenue. Valuation Update With 7 Day Price Move • Mar 08
Investor sentiment improved over the past week After last week's 16% share price gain to ₹10.50, the stock is trading at a trailing P/E ratio of 17.8x, up from the previous P/E ratio of 15.4x. This compares to an average P/E of 20x in the Medical Equipment industry in India. Total return to shareholders over the past three years is a loss of 17%. Reported Earnings • Feb 17
Third quarter 2021 earnings released: EPS ₹0.07 (vs ₹0.15 in 3Q 2020) The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: ₹19.2m (up 1.5% from 3Q 2020). Net income: ₹239.0k (down 56% from 3Q 2020). Profit margin: 1.2% (down from 2.9% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Feb 08
New 90-day low: ₹9.50 The company is down 17% from its price of ₹11.41 on 10 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 12% over the same period. Announcement • Feb 03
Shree Pacetronix Limited to Report Q3, 2021 Results on Feb 13, 2021 Shree Pacetronix Limited announced that they will report Q3, 2021 results on Feb 13, 2021 Is New 90 Day High Low • Jan 22
New 90-day low: ₹10.55 The company is down 12% from its price of ₹12.00 on 23 October 2020. The Indian market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 4.0% over the same period. Reported Earnings • Nov 13
Second quarter 2021 earnings released: EPS ₹0.06 The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹18.9m (down 24% from 2Q 2020). Net income: ₹216.0k (down 83% from 2Q 2020). Profit margin: 1.1% (down from 5.0% in 2Q 2020). The decrease in margin was driven by lower revenue. Is New 90 Day High Low • Nov 09
New 90-day low: ₹11.41 The company is down 3.0% from its price of ₹11.80 on 07 August 2020. The Indian market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 14% over the same period. Is New 90 Day High Low • Sep 28
New 90-day high: ₹13.23 The company is up 18% from its price of ₹11.20 on 22 June 2020. The Indian market is up 8.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Medical Equipment industry, which is up 55% over the same period. Announcement • Aug 26
Shree Pacetronix Limited to Report Q1, 2021 Results on Aug 25, 2020 Shree Pacetronix Limited announced that they will report Q1, 2021 results on Aug 25, 2020 
